Next Article in Journal
Synthetic Neuraminidase Vaccine Induces Cross-Species and Multi-Subtype Protection
Previous Article in Journal
A Bioconjugate Vaccine Against Extra-Intestinal Pathogenic Escherichia coli (ExPEC)
Previous Article in Special Issue
The Immunologic Downsides Associated with the Powerful Translation of Current COVID-19 Vaccine mRNA Can Be Overcome by Mucosal Vaccines
 
 
Article

Article Versions Notes

Vaccines 2025, 13(4), 363; https://doi.org/10.3390/vaccines13040363
Action Date Notes Link
article xml file uploaded 28 March 2025 13:55 CET Original file -
article xml uploaded. 28 March 2025 13:55 CET Update https://www.mdpi.com/2076-393X/13/4/363/xml
article pdf uploaded. 28 March 2025 13:55 CET Version of Record https://www.mdpi.com/2076-393X/13/4/363/pdf
article supplementary file uploaded. 28 March 2025 13:55 CET - https://www.mdpi.com/2076-393X/13/4/363#supplementary
article html file updated 28 March 2025 13:56 CET Original file https://www.mdpi.com/2076-393X/13/4/363/html
Back to TopTop